Vendor, Parsippany, NJ
Medicines Company, the
UEI ZCK2MH2VMA26, CAGE 37CG9
1 award and $10,000,000 obligated between April 22, 2024 and February 20, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $10,000,000 |
Industries
NAICS on the awards, by dollars.
| Professional, Scientific, and Technical ServicesNAICS 541711 | $10,000,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Hear when Medicines Company, the wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Medicines Company, the's contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling professional, scientific, and technical services to Office of Assistant Secretary for Preparedness and Response, by dollars.
| Hoffmann-La Roche Inc.Nutley, NJ | $67,872,020 |
| Dnae Group Holdings LimitedLondon | $0 |
| Fraunhofer Usa, Inc.Newark, DE | $0 |
| Novan Inc.Durham, NC | $0 |
| Profectus Biosciences, Inc.Baltimore, MD | -$1,012 |
| PPD Development, LPWilmington, NC | -$1,839 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSO100201600026CDefinitive Contract, April 22, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Modification 7 Performs the Following Actions: 1.) Activates Option 4 (Clin 0005) for Program Management, Non-Clinical Toxicology, Non-CliniNAICS 541711, PSC AN13 | $10,000,000 |
- Places of performance
- New Jersey
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 4 across 1 awards